Virpax Pharmaceuticals, Inc. short interest in 2024
In 2024, Virpax Pharmaceuticals, Inc.'s disclosed short interest ran from 3.14% of shares outstanding on 15 Aug 2024 to 9.36% on 31 Dec 2024, a change of +6.22 percentage points. The year's high was 9.36% on 31 Dec 2024 and its low 3.14% on 15 Aug 2024, averaging 6.49% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.07 days on 15 Nov 2024. Full history: Virpax Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024
2024 in figures
- Start of year
- 3.14% (15 Aug 2024)
- End of year
- 9.36% (31 Dec 2024)
- Change
- +6.22 pp
- High
- 9.36% (31 Dec 2024)
- Low
- 3.14% (15 Aug 2024)
- Average
- 6.49%
- Highest days to cover
- 3.07 (15 Nov 2024)
- SEC filings marked
- 7
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Aug 2024 | 3.14% | 1.00 | 10-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed, results (8-K) |
| 31 Oct 2024 | 7.18% | 1.00 | |
| 15 Nov 2024 | 6.45% | 3.07 | 10-Q filed |
| 29 Nov 2024 | 7.91% | 1.00 | |
| 13 Dec 2024 | 4.92% | 1.00 | |
| 31 Dec 2024 | 9.36% | 1.00 |
See also: Virpax Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.